Title : Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.

Pub. Date : 2019 Jul 4

PMID : 30445633






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus
2 Treatment of metformin led to activation of AMP-activated protein kinase (AMPK) and attenuated signaling of the downstream molecules such as p-mTOR, p-p70S6K and cyclin D1 expression both in vivo and in vitro. Metformin protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus